Seeking Alpha

QualityStocks'  Instablog

QualityStocks
Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
QualityStocks
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Rafarma Pharmaceuticals, Inc. (RAFA) Reports Registration Of CEFTRIAXONE Under International... 0 comments
    Apr 8, 2013 11:10 AM

    Rafarma Pharmaceuticals, Inc. (OTCPK:RAFA) Reports Registration of CEFTRIAXONE Under International Label

    Rafarma Pharmaceuticals, a Russia-based multi-product pharmaceutical company producing generic antibiotics and specialty pharmaceuticals in addition to its own line of proprietary products, just announced that ZAO "Rafarma" has registered (MHH) CEFTRIAXONE, a third-generation cephalosporin antibiotic, as a medication under international unpatented label.

    The antibiotic is typically used in combination for the treatment of pneumonia, bacterial meningitis, gonorrhea, and in pediatrics for the prevention of sepsis. According to today's press release, market capacity of CEFTRIAXONE in the Russian Federation last year totaled USD $85.7 million dollars, an increase of 20% compared to its capacity in 2011.

    Dave Anderson, CEO of Rafarma Pharmaceuticals, said, "Registering this product is complementary to our goal of producing high-quality pharmaceutical products. Rafarma is positioned to meet rising market demand for CEFTRIAXONE utilizing our state-of-the-art research facility and staff as we continue efforts to expand our product portfolio."

    "I'd also like to clarify that Rafarma's earlier announcement reporting its status as 1 of 4 National Strategic Pharmaceutical Suppliers to the Russian Federation in no way limits our ability to produce and manufacture products for qualified buyers globally," added Mr. Anderson. "We will offer CEFTRIAXONE, as well as all other products we produce, to the international market."

    For more information, visit Rafarma.com

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.